表紙
市場調查報告書

神經調節的全球市場:2020年∼2024年

Neuromodulation Market by Product and Geography - Forecast and Analysis 2020-2024

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 919945
出版日期 內容資訊 英文 167 Pages
訂單完成後即時交付
價格
Back to Top
神經調節的全球市場:2020年∼2024年 Neuromodulation Market by Product and Geography - Forecast and Analysis 2020-2024
出版日期: 2019年12月11日內容資訊: 英文 167 Pages
簡介

全球神經調節市場上,慢性疾病的盛行率和關聯的危險因素增加,意識提升舉措和獲得醫療保健的增加,技術的進步等成為成長促進因素,在預測期間內預計將以11%以上的年複合成長率擴大。但,與設備和治療的高成本,設備的限制根據併發症,及嚴格法規等要素,可能妨礙在預測期間內神經調節產業的成長。

本報告提供全球神經調節市場相關調查分析,市場規模及成長率,市場趨勢,市場的推動要素與課題,市場機會驗證,再加上主要供應商等相關的系統性資訊。

目錄

第1章 摘要整理

第2章 調查範圍

  • 簡介1
  • 簡介2
  • 美金的貨幣換算比率

第3章 市場情形

  • 市場生態系統
  • 市場特徵
  • 市場區隔分析
  • 價值鏈分析

第4章 市場規模

  • 市場定義
  • 市場規模(2019年)
  • 市場預測
  • 市場規模及預測(2019年∼2024年)

第5章 波特的五力分析

  • 買主談判力
  • 供應商談判力
  • 新加入廠商的威脅
  • 替代品的威脅
  • 競爭對手的威脅
  • 市場情況

第6章 市場區隔:各產品

  • 市場區隔:各產品
  • 各產品比較:市場規模及預測(2019年∼2024年)
  • 置入式設備
  • 外部設備
  • 市場機會:各產品

第7章 客戶形勢

第8章 各地區形勢

  • 各地區市場區隔
  • 各地區比較:市場規模及預測(2019年∼2024年)
  • 北美
  • 歐洲
  • 亞洲
  • 其他地區
  • 主要國家
  • 市場機會

第9章 決策架構

第10章 成長要素與課題

  • 市場成長要素
  • 市場課題

第11章 市場趨勢

  • 償付政策的改善
  • 策略性的合作與收購
  • 適應症的擴大

第12章 業者情勢

  • 概要
  • 創造性破壞狀況
  • 競爭方案

第13章 供應商分析

  • 交易廠商
  • 供應商分類
  • 供應商的市場定位
  • Abbott Laboratories
  • Boston Scientific Corp.
  • LivaNova Plc
  • Medtronic Plc
  • NeuroMetrix Inc.
  • Neuronetics Inc.
  • Nevro Corp.
  • Nuvectra Co.
  • OMRON
  • Zynex Inc.

第14章 附錄

  • 調查方法
  • 簡稱的清單
  • 供應商的市場定位定義

第15章 關於TECHNAVIO

目錄
Product Code: IRTNTR40310

About this market

Technavio's neuromodulation market analysis considers sales from implantable neuromodulation devices and external neuromodulation devices. Our study also finds the sales of neuromodulation in Asia, Europe, North America, and ROW. In 2019, the implantable neuromodulation devices segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as technological advances and new product launches will play a significant role in the implantable neuromodulation devices segment to maintain its market position. Also, our global neuromodulation market report looks at factors such as increasing prevalence of chronic diseases and related risk factors, increasing awareness initiatives and access to healthcare, and technological advances. However, high cost of devices and procedures, device limitations and complications, and stringent regulations may hamper the growth of the neuromodulation industry over the forecast period.

Overview

Technological advances

Technological advances related to battery longevity and miniaturization of implantable neuromodulation devices, including the circuitry and battery, device software and programming, introduction of rechargeable batteries, and implantation techniques, have significantly improved the reliability and effectiveness of neuromodulation devices. One of the latest technological advances in neuromodulation devices has been the development of MRI-conditional implantable neuromodulation devices. Such technological advances will lead to the expansion of the global neuromodulation market at a CAGR of over 11% during the forecast period.

Expanding indications

Several neuromodulation devices have recently received approval for indications and are ongoing clinical trials to explore their additional therapeutic properties. Some new indications that are currently being investigated for neuromodulation therapy include Alzheimer's, heart failure, stroke recovery, diabetic neuropathy, migraine headaches, refractory angina relief, hypertension, chronic respiratory insufficiency, and gastrointestinal disorders. Historically, neuropathic pain conditions have been difficult to treat as the pain stem from tissue and nerve damages or result from a disruption in how the peripheral and central nervous system processes or transmit pain signals. This development is expected to have a positive impact on the overall market growth.

For the detailed list of factors that will drive the global neuromodulation market during the forecast period 2020-2024, view our report.

Competitive Landscape

With the presence of several major players, the global neuromodulation market is fragmented. Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading neuromodulation manufacturers, that include Abbott Laboratories, Boston Scientific Corp., LivaNova Plc, Medtronic Plc, NeuroMetrix Inc., Neuronetics Inc., Nevro Corp., Nuvectra Co., OMRON Corp., and Zynex Inc.

Also, the neuromodulation market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

TABLE OF CONTENTS

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

  • 2.1 Preface
  • 2.2 Preface
  • 2.3 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis
  • Value chain analysis

PART 04: MARKET SIZING

  • Market definition
  • Market sizing 2019
  • Market Outlook
  • Market size and forecast 2019-2024

PART 05: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 06: MARKET SEGMENTATION BY PRODUCT

  • Market segmentation by product
  • Comparison by product
  • Implantable neuromodulation devices - Market size and forecast 2019-2024
  • External neuromodulation devices - Market size and forecast 2019-2024
  • Market opportunity by product

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • Asia - Market size and forecast 2019-2024
  • ROW - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity

PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 11: MARKET TRENDS

  • Improving reimbursement policies
  • Strategic collaborations and acquisitions
  • Expanding indications
  • PART 12: VENDOR LANDSCAPE
  • Overview
  • Landscape disruption
  • Competitive scenario

PART 13: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Abbott Laboratories
  • Boston Scientific Corp.
  • LivaNova Plc
  • Medtronic Plc
  • NeuroMetrix Inc.
  • Neuronetics Inc.
  • Nevro Corp.
  • Nuvectra Co.
  • OMRON Corp.
  • Zynex Inc.

PART 14: APPENDIX

  • Research methodology
  • List of abbreviations
  • Definition of market positioning of vendors

PART 15: EXPLORE TECHNAVIO

LIST OF EXHIBITS:

  • Exhibit 01: Global healthcare equipment market
  • Exhibit 02: Segments of global healthcare equipment market
  • Exhibit 03: Market characteristics
  • Exhibit 04: Market segments
  • Exhibit 05: Vendors: Key offerings
  • Exhibit 06: Market definition - Inclusions and exclusions checklist
  • Exhibit 07: Market size 2019
  • Exhibit 08: Global market: Size and forecast 2019-2024 ($ millions)
  • Exhibit 09: Global market: Year-over-year growth 2020-2024 (%)
  • Exhibit 10: Five forces analysis 2019
  • Exhibit 11: Five forces analysis 2024
  • Exhibit 12: Bargaining power of buyers
  • Exhibit 13: Bargaining power of suppliers
  • Exhibit 14: Threat of new entrants
  • Exhibit 15: Threat of substitutes
  • Exhibit 16: Threat of rivalry
  • Exhibit 17: Market condition - Five forces 2019
  • Exhibit 18: Product - Market share 2019-2024 (%)
  • Exhibit 19: Comparison by product
  • Exhibit 20: Implantable neuromodulation devices - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 21: Implantable neuromodulation devices - Year-over-year growth 2020-2024 (%)
  • Exhibit 22: External neuromodulation devices - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 23: External neuromodulation devices - Year-over-year growth 2020-2024 (%)
  • Exhibit 24: Market opportunity by product
  • Exhibit 25: Customer landscape
  • Exhibit 26: Market share by geography 2019-2024 (%)
  • Exhibit 27: Geographic comparison
  • Exhibit 28: North America - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 29: North America - Year-over-year growth 2020-2024 (%)
  • Exhibit 30: Number of people aged 65 years and above in EU countries in 2005 and 2018 (in millions)
  • Exhibit 31: Europe - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 32: Europe - Year-over-year growth 2020-2024 (%)
  • Exhibit 33: Number of people aged 65 years and above in Asian countries in 2005 and 2018 (in millions)
  • Exhibit 34: Asia - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 35: Asia - Year-over-year growth 2020-2024 (%)
  • Exhibit 36: ROW - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 37: ROW - Year-over-year growth 2020-2024 (%)
  • Exhibit 38: Key leading countries
  • Exhibit 39: Market opportunity
  • Exhibit 40: Impact of drivers and challenges
  • Exhibit 41: Vendor landscape
  • Exhibit 42: Landscape disruption
  • Exhibit 43: Vendors covered
  • Exhibit 44: Vendor classification
  • Exhibit 45: Market positioning of vendors
  • Exhibit 46: Abbott Laboratories - Vendor overview
  • Exhibit 47: Abbott Laboratories - Business segments
  • Exhibit 48: Abbott Laboratories - Organizational developments
  • Exhibit 49: Abbott Laboratories - Geographic focus
  • Exhibit 50: Abbott Laboratories - Segment focus
  • Exhibit 51: Abbott Laboratories - Key offerings
  • Exhibit 52: Boston Scientific Corp. - Vendor overview
  • Exhibit 53: Boston Scientific Corp. - Business segments
  • Exhibit 54: Boston Scientific Corp. - Organizational developments
  • Exhibit 55: Boston Scientific Corp. - Geographic focus
  • Exhibit 56: Boston Scientific Corp. - Segment focus
  • Exhibit 57: Boston Scientific Corp. - Key offerings
  • Exhibit 58: LivaNova Plc - Vendor overview
  • Exhibit 59: LivaNova Plc - Product segments
  • Exhibit 60: LivaNova Plc - Organizational developments
  • Exhibit 61: LivaNova Plc - Geographic focus
  • Exhibit 62: LivaNova Plc - Segment focus
  • Exhibit 63: LivaNova Plc - Key offerings
  • Exhibit 64: Medtronic Plc - Vendor overview
  • Exhibit 65: Medtronic Plc - Business segments
  • Exhibit 66: Medtronic Plc - Organizational developments
  • Exhibit 67: Medtronic Plc - Geographic focus
  • Exhibit 68: Medtronic Plc - Segment focus
  • Exhibit 69: Medtronic Plc - Key offerings
  • Exhibit 70: NeuroMetrix Inc. - Vendor overview
  • Exhibit 71: NeuroMetrix Inc. - Business segments
  • Exhibit 72: NeuroMetrix Inc. - Organizational developments
  • Exhibit 73: NeuroMetrix Inc. - Key offerings
  • Exhibit 74: Neuronetics Inc. - Vendor overview
  • Exhibit 75: Neuronetics Inc. - Business segments
  • Exhibit 76: Neuronetics Inc. - Organizational developments
  • Exhibit 77: Neuronetics Inc. - Geographic focus
  • Exhibit 78: Neuronetics Inc. - Key offerings
  • Exhibit 79: Nevro Corp. - Vendor overview
  • Exhibit 80: Nevro Corp. - Business segments
  • Exhibit 81: Nevro Corp. - Organizational developments
  • Exhibit 82: Nevro Corp. - Geographic focus
  • Exhibit 83: Nevro Corp. - Key offerings
  • Exhibit 84: Nuvectra Co. - Vendor overview
  • Exhibit 85: Nuvectra Co. - Business segments
  • Exhibit 86: Nuvectra Co. - Organizational developments
  • Exhibit 87: Nuvectra Co. - Geographic focus
  • Exhibit 88: Nuvectra Co. - Key offerings
  • Exhibit 89: OMRON Corp. - Vendor overview
  • Exhibit 90: OMRON Corp. - Business segments
  • Exhibit 91: OMRON Corp. - Organizational developments
  • Exhibit 92: OMRON Corp. - Geographic focus
  • Exhibit 93: OMRON Corp. - Segment focus
  • Exhibit 94: OMRON Corp. - Key offerings
  • Exhibit 95: Zynex Inc. - Vendor overview
  • Exhibit 96: Zynex Inc. - Business segments
  • Exhibit 97: Zynex Inc. - Organizational developments
  • Exhibit 98: Zynex Inc. - Key offerings
  • Exhibit 99: Validation techniques employed for market sizing
  • Exhibit 100: Definition of market positioning of vendors
Back to Top